SOPHiA GENETICS (SOPH) Short term Debt (2020)

SOPHiA GENETICS (SOPH) reported Short term Debt of $2.9 million for Q4 2020.

SOPHiA GENETICS (SOPH) Short term Debt (2020) Analysis & Trends

SOPHiA GENETICS (SOPH) has 1 years of Short term Debt data on file, last reported at $2.9 million in Q4 2020.

  • For the quarter ending Q4 2020, Short term Debt changed N/A year-over-year to $2.9 million; the trailing twelve-month figure through Dec 2020 stood at $2.9 million (changed N/A YoY), and the FY2020 full-year result was $2.9 million, changed N/A from the prior year.
  • Short term Debt held at $2.9 million in Q4 2020.
  • In the past five years, Short term Debt ranged from a high of $2.9 million in Q4 2020 to a low of $2.9 million in Q4 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Veeva Systems 29.34 Bn 22.03 Bn 662.02 Mn
2 BrightSpring Health Services 13.49 Bn 12.59 Bn 482.22 Mn
3 Healthequity 7.96 Bn 7.70 Bn 256.31 Mn
4 10x Genomics 6.17 Bn 5.63 Bn 106.18 Mn
5 Hinge Health 6.02 Bn 5.70 Bn 154.23 Mn
6 MiniMed 4.19 Bn 3.89 Bn 480.00 Mn
7 Waystar Holding 4.14 Bn 4.07 Bn 216.84 Mn
8 Doximity 3.82 Bn 3.08 Bn 125.97 Mn
9 Privia Health 3.10 Bn 2.73 Bn -
10 SOPHiA GENETICS 408.62 Mn 338.33 Mn 14.69 Mn

Historic Data

Download Data
DateValue
Dec 31, 2020 2.87 Mn